NEW DELHI: The Subject Matter Expert Committee (SEC) of the national drug regulator is likely to hold a meeting with Bharat Biotech on Saturday to consider your Covid-19 vaccine applicant, Covaxin. The committee constituted by the Central Organization for the Control of Medicines Standards on Friday had held that the …
Read More »